Insider · CIK 0001274225
Dennis Langer
Files at QNRX (Quoin Pharmaceuticals, Ltd.). First filing Oct 15, 2025, latest Oct 15, 2025.
In brief
Dennis Langer files SEC Form 4 as director at QNRX (Quoin Pharmaceuticals, Ltd.). Since Oct 15, 2025, Dennis Langer has reported 1 open-market buy worth $129k and 0 open-market sells worth $0, the latest filed on Oct 15, 2025.
A track record needs three past buys with six months of prices behind them; Dennis Langer has 0, so none is measured yet.
The newest scored trade: bought $129k of QNRX on Oct 14, 2025, filed Oct 15, 2025, scored 44 (moderate). In the last 12 months: 1 buy worth $129k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
QNRX: Quoin Pharmaceuticals, Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | QNRXbuy Quoin Pharmaceuticals, Ltd. | $129k 15,152 shares | first purchase | +166% from low-54% from high |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award ADSs | +34,534 | $5.15 | $178k | 56,243 | Aug 28, 2026 |
| Feb 4, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +21,709 | $0.00 | $0 | 21,709 | Feb 6, 2026 |
| Oct 14, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase ADSs | +15,152 | $8.49 | $129k | 15,153 | Oct 15, 2025 |
| Oct 14, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase Series H Warrants (Right to Buy)derivative | +15,152 | - | - | 15,152 | Oct 15, 2025 |
| Oct 14, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase Series I Warrants (Right to Buy)derivative | +15,152 | - | - | 15,152 | Oct 15, 2025 |
| Oct 14, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase Series J Warrants (Right to Buy)derivative | +15,152 | - | - | 15,152 | Oct 15, 2025 |
| Oct 14, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase Series K Warrants (Right to Buy)derivative | +15,152 | - | - | 15,152 | Oct 15, 2025 |
| Aug 21, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +13,682 | $0.00 | $0 | 13,682 | Aug 25, 2025 |
| May 29, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +7,760 | $0.00 | $0 | 7,760 | Jun 2, 2025 |
| Dec 9, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +50,714 | $0.00 | $0 | 50,714 | Dec 10, 2024 |
| Oct 26, 2023 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +7,652 | $0.00 | $0 | 7,652 | Oct 30, 2023 |
Questions about Dennis Langer
Answered from the filings on this page, as of the latest one.
Is Dennis Langer buying or selling?
In the last 12 months Dennis Langer reported 1 open-market buy worth $129k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $129k of QNRX on Oct 14, 2025. Grants, option exercises and tax withholding are not counted.
How did Dennis Langer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dennis Langer has 0.
Where does Dennis Langer file Form 4?
Dennis Langer has filed Form 4 at QNRX (Quoin Pharmaceuticals, Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.